company
as of 2026-07-01Neurocrine Biosciences
at a glance
19 trials sponsored · 9 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
9 assets
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Luvadaxistat
drugsmall molecule
NBI-1117568
drugsmall molecule
NBI-1117570
drugsmall molecule
NBI-98854
drugsmall molecule
Second Generation Antipsychotics (SGA)
drugsmall molecule
TAK-041
drugsmall molecule
TAK-831 Oral Suspension
drugsmall molecule
TAK-831 Tablet
drugsmall molecule